Paholpak Permsak, Sirichativapee Winai, Wisanuyotin Taweechok, Kosuwon Weerachai, Jeeravipoolvarn Polasak
Department of Orthopedics, Faculty of Medicine, Khon Kaen University, Khon Kaen, 40002, Thailand.
Open Orthop J. 2012;6:440-4. doi: 10.2174/1874325001206010440. Epub 2012 Oct 3.
A retrospective study.
THREE OBJECTIVES HAVE BEEN DESIGNATED FOR THIS STUDY: (1) to determine the prevalence of identifiable and non-identifiable primary tumor sites in patients with spinal metastasis, (2) to identify the most common site of the known primary tumor sites, and (3) to identify the factors associated with survival time.
The spine is the third most common metastatic site for several primary visceral carcinomas. The primary tumor site could not be identified in 15% to 20% of patients who had been diagnosed of with a skeletal metastasis. Most of the previous studies on skeletal metastasis have not been limited to spinal metastasis alone.
Between January 2007 and July 2011 reviews were done for 82 patients with spinal metastasis who had not received a previous diagnosis of carcinoma. The assessment parameters included the following: general demographic data, Karnofsky score, Frankel score, number of spinal vertebra affected, region of the spine affected by metastasis, other skeletal metastasis site, visceral metastasis, known or unknown primary sites of metastasis, histological cell type of metastasis, and the survival period. The log-rank test and Cox proportional hazard model were used to study the survival analysis.
Of the 82 patients included in the study, 56 were male. The mean age was 57 years. 86.6% had a known primary carcinoma site while the remaining 13.4% had none. The two most common known carcinoma sites were the lung and biliary systems. Among the 11 unknown primary sites, the most common histological finding was adenocarcinoma. The mean survival period was 8.7 ± 11.7 months. The survival analysis revealed two statistically significant factors: the primary tumor site's aggressiveness (P<0.005) and the presence of visceral metastasis (P<0.05).
The prevalence of identifiable primary site was 86.6% and the most common site was the lungs followed by the biliary system. The primary carcinoma site's aggressiveness and the presence of visceral metastasis were the factors associated with patient survival.
一项回顾性研究。
本研究设定了三个目标:(1)确定脊柱转移患者中可识别和不可识别的原发肿瘤部位的患病率,(2)识别已知原发肿瘤部位中最常见的部位,以及(3)识别与生存时间相关的因素。
脊柱是几种原发性内脏癌的第三大常见转移部位。在被诊断为骨转移的患者中,15%至20%的患者无法确定原发肿瘤部位。以前关于骨转移的大多数研究并不局限于单纯的脊柱转移。
对2007年1月至2011年7月期间82例此前未被诊断为癌症的脊柱转移患者进行回顾。评估参数包括以下内容:一般人口统计学数据、卡诺夫斯基评分、弗兰克尔评分、受累脊椎数量、转移累及的脊柱区域、其他骨转移部位、内脏转移、已知或未知的转移原发部位、转移的组织学细胞类型以及生存期。采用对数秩检验和Cox比例风险模型进行生存分析。
纳入研究的82例患者中,56例为男性。平均年龄为57岁。86.6%的患者有已知的原发癌部位,其余13.4%的患者没有。两个最常见的已知癌部位是肺和胆道系统。在11个未知原发部位中,最常见的组织学发现是腺癌。平均生存期为8.7±11.7个月。生存分析显示两个具有统计学意义的因素:原发肿瘤部位的侵袭性(P<0.005)和内脏转移的存在(P<0.05)。
可识别原发部位的患病率为86.6%,最常见的部位是肺,其次是胆道系统。原发癌部位的侵袭性和内脏转移的存在是与患者生存相关的因素。